Characterization and Regional Distribution of ?2-Adrenoceptors in Postmortem Human Brain Using the Full Agonist [3H]UK 14304
- 1 April 1989
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 52 (4), 1210-1217
- https://doi.org/10.1111/j.1471-4159.1989.tb01868.x
Abstract
The full agonist [3H]UK 14304 [5-bromo-6-(2-imidazolin-2-yl-amino)-quinoxaline] was used to characterize alpha 2-adrenoceptors in postmortem human brain. The binding at 25 degrees C was rapid (t1/2, 4.6 min) and reversible (t1/2, 14.1 min), and the KD determined from the kinetic studies was 0.48 nM. In frontal cortex, the rank order of potency of adrenergic drugs competing with [3H]UK 14304 or [3H]clonidine showed the specificity for an alpha 2A-adrenoceptor: UK 14304 approximately equal to yohimbine approximately equal to oxymetazoline approximately equal to clonidine greater than phentolamine approximately equal to (-)-adrenaline greater than idazoxan approximately equal to (-)-noradrenaline greater than phenylephrine greater than (+/-)-adrenaline much greater than corynanthine greater than prazosin much greater than (+/-)-propranolol. GTP induced a threefold decrease in the affinity of [3H]UK 14304, with no alteration in the maximum number of binding sites, suggesting that the radioligand labelled the high-affinity state of the alpha 2-adrenoceptor. In the frontal cortex, analyses of saturation curves indicated the existence of a single population of noninteracting sites for [3H]UK 14304 (KD = 0.35 +/- 0.13 nM; Bmax = 74 +/- 9 fmol/mg of protein). In other brain regions (hypothalamus, hippocampus, cerebellum, brainstem, caudate nucleus, and amygdala) the Bmax ranged from 68 +/- 7 to 28 +/- 4 fmol/mg of protein. No significant changes in the KD values were found in the different regions examined. The binding of [3H]UK 14304 was not affected by age, sex or postmortem delay.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 28 references indexed in Scilit:
- Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medullaEuropean Journal of Pharmacology, 1987
- Labelling of human platelet α2-adrenoceptors with the full agonist [3H](−)adrenalineEuropean Journal of Pharmacology, 1986
- [3H]clonidine binds at multiple high affinity states in human prefrontal cortexEuropean Journal of Pharmacology, 1986
- Heterogeneity of alpha-2 adrenergic receptorsPharmacology Biochemistry and Behavior, 1985
- Adrenergic receptors in frontal cortex in human brainEuropean Journal of Pharmacology, 1985
- Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicidesNeuropharmacology, 1984
- Quantitative analysis of rat brain α2-receptors discriminated by [3H]clonidine and [3H]rauwolscineEuropean Journal of Pharmacology, 1984
- Effects of α2‐adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human plateletsBritish Journal of Pharmacology, 1984
- UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypesEuropean Journal of Pharmacology, 1981
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973